U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H18F4N4O3S
Molecular Weight 482.451
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-(3-(4-(AMINOCARBONYL)-3-(TRIFLUOROMETHYL)PHENYL)-5,5-DIMETHYL-4-OXO-2-THIOXO-1-IMIDAZOLIDINYL)-2-FLUORO-N-METHYLBENZAMIDE

SMILES

CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C(N)=O)C(F)(F)F

InChI

InChIKey=LHWIIZPVBJLMTC-UHFFFAOYSA-N
InChI=1S/C21H18F4N4O3S/c1-20(2)18(32)28(10-4-6-12(16(26)30)14(8-10)21(23,24)25)19(33)29(20)11-5-7-13(15(22)9-11)17(31)27-3/h4-9H,1-3H3,(H2,26,30)(H,27,31)

HIDE SMILES / InChI

Molecular Formula C21H18F4N4O3S
Molecular Weight 482.451
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Thu Jul 06 20:26:22 UTC 2023
Edited
by admin
on Thu Jul 06 20:26:22 UTC 2023
Record UNII
HZ7ZZC4TC6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
4-(3-(4-(AMINOCARBONYL)-3-(TRIFLUOROMETHYL)PHENYL)-5,5-DIMETHYL-4-OXO-2-THIOXO-1-IMIDAZOLIDINYL)-2-FLUORO-N-METHYLBENZAMIDE
Systematic Name English
BENZAMIDE, 4-(3-(4-(AMINOCARBONYL)-3-(TRIFLUOROMETHYL)PHENYL)-5,5-DIMETHYL-4-OXO-2-THIOXO-1-IMIDAZOLIDINYL)-2-FLUORO-N-METHYL-
Systematic Name English
ENZALUTAMIDE METABOLITE M7
Common Name English
Code System Code Type Description
PUBCHEM
156596417
Created by admin on Thu Jul 06 20:26:23 UTC 2023 , Edited by admin on Thu Jul 06 20:26:23 UTC 2023
PRIMARY
FDA UNII
HZ7ZZC4TC6
Created by admin on Thu Jul 06 20:26:23 UTC 2023 , Edited by admin on Thu Jul 06 20:26:23 UTC 2023
PRIMARY
CAS
2030242-21-6
Created by admin on Thu Jul 06 20:26:23 UTC 2023 , Edited by admin on Thu Jul 06 20:26:23 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
Metabolite M7 was trace component in plasma; accounting for ≤ 2% of the radioactivity in the 6- and 24-hour postdose plasma samples and not detected at any other time point. In urine, M7 accounted for 9.45% of the radioactive dose. In feces, M7 accounted for 1.12% of the radioactive dose.
FECAL; PLASMA; URINE